Royal Bank of Canada’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.3M | Sell |
953,413
-10,411
| -1% | -$347K | ﹤0.01% | 1256 |
|
|
2026
Q1 | $29M | Buy |
963,824
+96,938
| +11% | +$3.12M | 0.01% | 1207 |
|
|
2025
Q4 | $27.1M | Sell |
866,886
-29,911
| -3% | -$737K | ﹤0.01% | 1285 |
|
|
2025
Q3 | $18.1M | Sell |
896,797
-850,354
| -49% | -$14.9M | ﹤0.01% | 1730 |
|
|
2025
Q2 | $29.3M | Buy |
1,747,151
+565,187
| +48% | +$9.12M | 0.01% | 1269 |
|
|
2025
Q1 | $18.2M | Buy |
1,181,964
+4,361
| +0.4% | +$77.9K | ﹤0.01% | 1366 |
|
|
2024
Q4 | $26M | Buy |
1,177,603
+173,050
| +17% | +$3.15M | 0.01% | 1191 |
|
|
2024
Q3 | $18.1M | Buy |
1,004,553
+489,755
| +95% | +$8.57M | ﹤0.01% | 1401 |
|
|
2024
Q2 | $8.37M | Buy |
514,798
+118,716
| +30% | +$1.83M | ﹤0.01% | 1794 |
|
|
2024
Q1 | $5.59M | Buy |
396,082
+73,991
| +23% | +$933K | ﹤0.01% | 2085 |
|
|
2023
Q4 | $3.36M | Sell |
322,091
-2,300
| -0.7% | -$21.5K | ﹤0.01% | 2592 |
|
|
2023
Q3 | $3.31M | Sell |
324,391
-5,280
| -2% | -$49.2K | ﹤0.01% | 2418 |
|
|
2023
Q2 | $2.48M | Buy |
329,671
+62,522
| +23% | +$507K | ﹤0.01% | 2664 |
|
|
2023
Q1 | $2.37M | Buy |
267,149
+10,137
| +4% | +$100K | ﹤0.01% | 2679 |
|
|
2022
Q4 | $2.34M | Sell |
257,012
-202,725
| -44% | -$1.77M | ﹤0.01% | 2773 |
|
|
2022
Q3 | $3.71M | Buy |
459,737
+63,560
| +16% | +$562K | ﹤0.01% | 2315 |
|
|
2022
Q2 | $2.98M | Sell |
396,177
-548,244
| -58% | -$4.78M | ﹤0.01% | 2526 |
|
|
2022
Q1 | $8.87M | Sell |
944,421
-158,744
| -14% | -$1.32M | ﹤0.01% | 1803 |
|
|
2021
Q4 | $8.84M | Buy |
1,103,165
+123,491
| +13% | +$1.11M | ﹤0.01% | 1976 |
|
|
2021
Q3 | $9.54M | Buy |
979,674
+243,822
| +33% | +$2.28M | ﹤0.01% | 1850 |
|
|
2021
Q2 | $7.29M | Buy |
735,852
+12,982
| +2% | +$137K | ﹤0.01% | 2039 |
|
|
2021
Q1 | $8.34M | Sell |
722,870
-211,996
| -23% | -$2.43M | ﹤0.01% | 1883 |
|
|
2020
Q4 | $9.02M | Buy |
934,866
+482,596
| +107% | +$4.62M | ﹤0.01% | 1791 |
|
|
2020
Q3 | $4.08M | Sell |
452,270
-40,247
| -8% | -$426K | ﹤0.01% | 2148 |
|
|
2020
Q2 | $6.07M | Buy |
492,517
+20,423
| +4% | +$231K | ﹤0.01% | 1799 |
|
|
2020
Q1 | $4.24M | Sell |
472,094
-4,601
| -1% | -$47.1K | ﹤0.01% | 1933 |
|
|
2019
Q4 | $4.67M | Sell |
476,695
-572,322
| -55% | -$5.11M | ﹤0.01% | 2205 |
|
|
2019
Q3 | $7.22M | Buy |
1,049,017
+421,092
| +67% | +$3.23M | ﹤0.01% | 1805 |
|
|
2019
Q2 | $5.79M | Sell |
627,925
-334,488
| -35% | -$4.03M | ﹤0.01% | 1961 |
|
|
2019
Q1 | $15.1M | Sell |
962,413
-162,203
| -14% | -$2.86M | 0.01% | 1247 |
|
|
2018
Q4 | $17.3M | Buy |
1,124,616
+170,778
| +18% | +$3.5M | 0.01% | 1082 |
|
|
2018
Q3 | $20.5M | Buy |
953,838
+12,710
| +1% | +$295K | 0.01% | 1115 |
|
|
2018
Q2 | $22.9M | Sell |
941,128
-104,393
| -10% | -$2.13M | 0.01% | 996 |
|
|
2018
Q1 | $17.9M | Sell |
1,045,521
-223,790
| -18% | -$4.37M | 0.01% | 1169 |
|
|
2017
Q4 | $24.1M | Sell |
1,269,311
-594,400
| -32% | -$8.94M | 0.01% | 1018 |
|
|
2017
Q3 | $32.8M | Sell |
1,863,711
-818,174
| -31% | -$18.4M | 0.02% | 781 |
|
|
2017
Q2 | $89.1M | Sell |
2,681,885
-136,052
| -5% | -$4.21M | 0.05% | 322 |
|
|
2017
Q1 | $90.4M | Sell |
2,817,937
-36,405
| -1% | -$1.24M | 0.05% | 305 |
|
|
2016
Q4 | $103M | Buy |
2,854,342
+604,236
| +27% | +$24.1M | 0.06% | 289 |
|
|
2016
Q3 | $104M | Sell |
2,250,106
-17,878
| -0.8% | -$933K | 0.06% | 276 |
|
|
2016
Q2 | $114M | Buy |
2,267,984
+154,377
| +7% | +$8.22M | 0.07% | 229 |
|
|
2016
Q1 | $113M | Buy |
2,113,607
+317,822
| +18% | +$18.6M | 0.07% | 217 |
|
|
2015
Q4 | $118M | Sell |
1,795,785
-8,664
| -0.5% | -$535K | 0.08% | 198 |
|
|
2015
Q3 | $102M | Buy |
1,804,449
+1,515
| +0.1% | +$98.2K | 0.08% | 187 |
|
|
2015
Q2 | $107M | Buy |
1,802,934
+236,231
| +15% | +$14.6M | 0.07% | 190 |
|
|
2015
Q1 | $97.6M | Buy |
1,566,703
+244,586
| +18% | +$14.2M | 0.07% | 204 |
|
|
2014
Q4 | $76M | Buy |
1,322,117
+53,423
| +4% | +$2.98M | 0.05% | 294 |
|
|
2014
Q3 | $68.2M | Buy |
1,268,694
+3,061
| +0.2% | +$162K | 0.05% | 286 |
|
|
2014
Q2 | $66.3M | Sell |
1,265,633
-263,263
| -17% | -$13.5M | 0.04% | 295 |
|
|
2014
Q1 | $80.8M | Sell |
1,528,896
-199,798
| -12% | -$9.23M | 0.06% | 239 |
|
|
2013
Q4 | $69.3M | Sell |
1,728,694
-939,331
| -35% | -$37M | 0.05% | 290 |
|
|
2013
Q3 | $101M | Sell |
2,668,025
-659,493
| -20% | -$25.7M | 0.08% | 187 |
|
|
2013
Q2 | $130M | Buy |
+3,327,518
| New | +$130M | 0.11% | 126 |
|
Other funds holding TEVA
HIIFS
PF
CI
MMH
MIFH
LIM
Royal Bank of Canada's TEVA Position: Q2 2026 in Review
Royal Bank of Canada reduced its Teva Pharmaceuticals (TEVA) stake by 1.1% in Q2 2026, selling an estimated $347K and leaving 953,413 shares worth $32.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1256.
Royal Bank of Canada first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $130M in Q2 2013. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.
- Royal Bank of Canada held 953,413 shares of Teva Pharmaceuticals worth $32.3M as of Q2 2026.
- Royal Bank of Canada sold 10,411 Teva Pharmaceuticals shares in Q2 2026, an estimated $347K.
- Teva Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #1256 holding.
- Royal Bank of Canada first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Royal Bank of Canada's Teva Pharmaceuticals position peaked at $130M in Q2 2013.
- 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.